Ongoing Research
A Phase III Open-Label Extension Study to Evaluate the Long-Term Safety of Astegolimab in Patients With Chronic Obstructive Pulmonary Disease
Principal Investigator — Dr. Charles Y. Yu
Status — Ongoing
Multi-center, double-blind, randomized, placebo-controlled, parallel-group study to evaluate the efficacy and safety of self-administered subcutaneous selatogrel for prevention of all-cause death and treatment of acute myocardial infarction in subjects with a recent history of acute myocardial infarction
Principal Investigator — Dr. Andre Luis R. Agoncillo
Status — Ongoing
A Phase III double-blind, randomised, parallel-group superiority trial to evaluate efficacy and safety of the combined use of oral vicadrostat (BI 690517) and empagliflozin compared with placebo and empagliflozin in participants with type 2 diabetes, hypertension and established cardiovascular disease
Principal Investigator — Dr. David Raymund K. Salvador
Status — Ongoing
Phase 3, Global, Randomized, Double-blind, Placebo-controlled, Safety and immunogenicity Study of CHIKV VLP Vaccine in Children 2 to <12 Years of Age
Principal Investigator — Dr. Delia C. Yu
Status — Ongoing
An open label randomised-controlled trial to evaluate the benefit-risk of 1-month rifapentine and isoniazid compared to standard of care to prevent tuberculosis and reduce morbidity in people with diabetes in South Africa
Principal Investigator — Dr. Charles Y. Yu
Status — Ongoing
A Phase III, Randomised, Double-blind, Placebo-controlled, Parallel-group Study to Assess the Effect of AZD0780 on Major AdverseCardiovascular Events in Patients with Established Atherosclerotic Cardiovascular Disease (ASCVD) or at High Risk for a First ASCVD Even
Principal Investigator — Dr. Andre Luis R. Agoncillo
Status — Ongoing
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Verekitug in Adolescent and Adult Participants with Severe Asthma
Principal Investigator — Dr. Charles Y. Yu
Status — Ongoing
Comparative Validation and Concordance Analysis of QIAstat-Dx and BioFire Respiratory Panels for SARS-CoV-2 Detection in Clinical Respiratory Specimens
Principal Investigator — Dr. Charles Y. Yu
Co-Investigator — Dr. Ethel Anonuevo
Asian Hospital and Medical Center in collaboration w Phil Genome Center (PGC)/FAS/Qiagen
Status — Ongoing